Stimulation of TREM2 with agonistic antibodies—an emerging therapeutic option for Alzheimer's disease
Kai Schlepckow, Estrella Morenas‐Rodríguez, Soyon Hong, Christian Haass
Topics & Concepts
TREM2MicrogliaDiseaseAlzheimer's diseaseAntibodyImmunologyBiomarkerMedicineNeuroscienceBiologyInternal medicineInflammationGeneticsNeuroinflammation and Neurodegeneration MechanismsInflammation biomarkers and pathwaysNeurological Disease Mechanisms and Treatments